Literature DB >> 34257757

Prosthetic aortic valve dehiscence following infective endocarditis by a rare bacterium - Pandoraea pnomenusa.

Atit A Gawalkar1, Ganesh Kasinadhuni1, Rimjhim Kanaujia2, Palanivel Rajan1, Jyoti Vijay1, Pruthvi C Revaiah1, Pallab Ray2, Rajesh Vijayvergiya1.   

Abstract

Late prosthetic valve endocarditis (PVE) is a life-threatening condition, commonly caused by bacterial organisms such as staphylococci, streptococci, or enterococci. Infrequently, it can be caused by rare organisms. We hereby report a case of late PVE of the aortic valve, due to a rare gram-negative bacterium Pandoraea pnomenusa. It is the first reported case of PVE caused by this particular organism. The patient had infective endocarditis-induced prosthetic valve dehiscence, severe aortic regurgitation, and shock, which was managed with appropriate antibiotics and supportive medical treatment. <Learning objective: Late prosthetic valve infective endocarditis should always be an important differential diagnosis in patients with artificial valve presenting with congestive cardiac failure. This case report is about aortic valve dehiscence and acute aortic regurgitation because of prosthetic valve infective endocarditis due to a rare bacterium Pandoraea pnomenusa.>.
© 2020 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aortic valve dehiscence; Infective endocarditis; Pandoraea pnomenusa; Para-valvular regurgitation; Prosthetic valve endocarditis

Year:  2020        PMID: 34257757      PMCID: PMC8258266          DOI: 10.1016/j.jccase.2020.12.003

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

1.  Assignment of CDC weak oxidizer group 2 (WO-2) to the genus Pandoraea and characterization of three new Pandoraea genomospecies.

Authors:  M I Daneshvar; D G Hollis; A G Steigerwalt; A M Whitney; L Spangler; M P Douglas; J G Jordan; J P MacGregor; B C Hill; F C Tenover; D J Brenner; R S Weyant
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

Review 2.  Infective endocarditis with negative blood cultures.

Authors:  Christoph K Naber; Raimund Erbel
Journal:  Int J Antimicrob Agents       Date:  2007-09-24       Impact factor: 5.283

3.  Natural history of early aortic paraprosthetic regurgitation: a five-year follow-up.

Authors:  L S Rallidis; I E Moyssakis; I Ikonomidis; P Nihoyannopoulos
Journal:  Am Heart J       Date:  1999-08       Impact factor: 4.749

Review 4.  Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association.

Authors:  Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Imad M Tleyjeh; Michael J Rybak; Bruno Barsic; Peter B Lockhart; Michael H Gewitz; Matthew E Levison; Ann F Bolger; James M Steckelberg; Robert S Baltimore; Anne M Fink; Patrick O'Gara; Kathryn A Taubert
Journal:  Circulation       Date:  2015-09-15       Impact factor: 29.690

5.  Prosthetic valve endocarditis. A survey.

Authors:  M Ben Ismail; N Hannachi; F Abid; Z Kaabar; J F Rougé
Journal:  Br Heart J       Date:  1987-07

6.  Sepsis, multiple organ failure, and death due to Pandoraea pnomenusa infection after lung transplantation.

Authors:  Martin E Stryjewski; John J LiPuma; Robert H Messier; L Barth Reller; Barbara D Alexander
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

7.  2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).

Authors:  Gilbert Habib; Patrizio Lancellotti; Manuel J Antunes; Maria Grazia Bongiorni; Jean-Paul Casalta; Francesco Del Zotti; Raluca Dulgheru; Gebrine El Khoury; Paola Anna Erba; Bernard Iung; Jose M Miro; Barbara J Mulder; Edyta Plonska-Gosciniak; Susanna Price; Jolien Roos-Hesselink; Ulrika Snygg-Martin; Franck Thuny; Pilar Tornos Mas; Isidre Vilacosta; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

8.  Non-HACEK gram-negative bacillus endocarditis.

Authors:  Susan Morpeth; David Murdoch; Christopher H Cabell; Adolf W Karchmer; Paul Pappas; Donald Levine; Francisco Nacinovich; Pierre Tattevin; Núria Fernández-Hidalgo; Stuart Dickerman; Emilio Bouza; Ana del Río; Tatjana Lejko-Zupanc; Auristela de Oliveira Ramos; Diana Iarussi; John Klein; Catherine Chirouze; Roger Bedimo; G Ralph Corey; Vance G Fowler
Journal:  Ann Intern Med       Date:  2007-12-18       Impact factor: 25.391

9.  Genome Sequences of Two Pandoraea pnomenusa Isolates Recovered 11 Months Apart from a Cystic Fibrosis Patient.

Authors:  Robson Ee; Mark Ambrose; James Lazenby; Paul Williams; Kok-Gan Chan; Louise Roddam
Journal:  Genome Announc       Date:  2015-02-05

10.  Isolation and identification of Pandoraea spp. From bronchoalveolar lavage of cystic fibrosis patients in Iran.

Authors:  Mohammad Tabatabaei; Mahdi Dastbarsar; Mohammad Ashkan Moslehi
Journal:  Ital J Pediatr       Date:  2019-09-02       Impact factor: 2.638

  10 in total
  2 in total

1.  Clinical and microbiological features of obstructive cholangitis with bloodstream infection caused by Pandoraea apista identified by MALDI-TOF mass spectrometry and ribosomal RNA sequencing in a cancer patient.

Authors:  Naoya Itoh; Nana Akazawa; Yuichi Ishibana; Toshiki Masuishi; Akinobu Nakata; Hiromi Murakami
Journal:  BMC Infect Dis       Date:  2022-06-07       Impact factor: 3.667

2.  Pandoraea pnomenusa Superinfection in a Patient with SARS-CoV-2 Pneumonia: First Case in the Literature.

Authors:  Diego Alejandro Cubides-Diaz; Natalia Muñoz Angulo; Daniel Augusto Martin Arsanios; Ana Lucia Ovalle Monroy; Daniel Ricardo Perdomo-Rodriguez; Maria Paula Del-Portillo
Journal:  Infect Dis Rep       Date:  2022-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.